| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 150 | / | 2021 | ||||||||
| Date of issue: | 2021-11-30 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, November 30, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of November 30, 2021, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows: | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_buy-back_30112021_EN_espi_150.pdf | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2021-11-30 | Ognian Donev | Executive Director | |||